Survival of malignant lymphoma of the neck is mainly related to the pathological type of the tumor, tumor stage, as well as the patient’s underlying health condition, age and other factors, which should be analyzed specifically and not generalized. Malignant lymphoma of the neck mainly includes Hodgkin’s lymphoma and non-Hodgkin’s lymphoma, and the treatment for such diseases has gained greater progress. Among them, Hodgkin’s lymphoma has become one of the tumors that can be cured through standardized treatment, and most patients can survive as normal after cure, and their life expectancy will not be significantly affected if there is no recurrence or metastasis. If the patient has non-Hodgkin’s lymphoma, prognosis and survival vary depending on the different risk factors the patient has. It is generally accepted that the more risk factors a patient has, the worse the prognosis and the shorter the survival. These risk factors include age over 60 years, tumor stage III or IV, multiple metastases from sites outside the lymph nodes, and being bedridden and needing care from others. Therefore, exactly how long a patient with malignant lymphoma of the neck can live varies from person to person. However, no matter which type of malignant lymphoma of the neck, after the disease should actively go to regular hospitals to receive treatment, only timely and standardized treatment can effectively alleviate the patient’s uncomfortable symptoms and prolong life.